✨ Health Notices




8 SEPTEMBER NEW ZEALAND GAZETTE 2783

executed on the 22nd day of August 1994. A copy of the supplementary agreement is available for inspection without charge by any member of the public at the district office of the Ministry of Education.

Dated at Wellington this 23rd day of August 1994.

K. PHILLIPS, Senior Manager, National Operations.

go6531

Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Nicotine 10 mg/ml Solution Kabi Pharmacia Therapeutics AB, Helsingborg, Sweden Nicorette Nasal Spray
Beclomethasone dipropionate Spray (oral metered) Orion Corporation Fermion, Orionintie 1, Espoo, Finland Atomide 100 Inhaler
100 mcg per actuation
Morphine sulphate 20 mg; Capsules Faulding Pharmaceuticals, Salisbury South, South Australia, Kapanol
50 mg, 100 mg (sustained release) Australia
Note: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent.
Tenoxicam 20 mg Tablet F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Suppository F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Powder for solution (milk) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Tablet (effervescent) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Tablet F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Suppository F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Powder for solution (milk) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Tablet (effervescent) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
Tenoxicam 20 mg Powder for injection F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil
(glass vial and diluent)
Diclofenac sodium 0.1% w/v Eye drops Ciba Vision AG, Hettlingen, Switzerland Voltaren Ophtha
Verapamil hydrochloride Tablets Knoll AG, Ludwigshafen, Germany Isoptin SR
120 mg, 240 mg (sustained release)
Famotidine 10 mg Tablet Merck Sharp & Dohme Limited, Cramlington, Northumberland, Pepcid AC
England
Apraclonidine hydrochloride Ophthalmic solution Alcon Laboratories Inc., Fort Worth, Texas, United States Iopidine 0.5% Solution
5.75 mg equivalent to apraclonidine base 5 mg per ml and S A Alcon Couvreur N V, Puurs, Belgium

Dated this 2nd day of September 1994.

C. LOVEACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

go6642

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1994, No 91


NZLII PDF NZ Gazette 1994, No 91





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
2 September 1994
Medicines, Distribution, Consent, Medicines Act 1981
  • C. Loveace, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981